References
- Boyle J, Eriksson ME, Gribble L, et al. Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care. 2012; 35:2451-8 https://doi.org/10.2337/dc12-0656
- Chung KJ, Lee JH, Hwang CJ, Ahn MW. A Treatment Guideline for Neuropathic Pain. J Korean Soc Spine Surg. 2011;18:246-53. https://doi.org/10.4184/jkss.2011.18.4.246
- Kathleen A. Head, ND. Peripheral Neuropathy: Pathogenic Mechanisms and Alternative Therapies. Alternative Medicine Review. 2006;11:294-329.
- Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003;26: 770-6. https://doi.org/10.2337/diacare.26.3.770
- Sima AA, Calvani M, Mehra M, Amato. A Acetyl-Lcarnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care. 2005;28:89-94. https://doi.org/10.2337/diacare.28.1.89
- Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care. 1998;21:1915-8 https://doi.org/10.2337/diacare.21.11.1915
- van Dam PS, van Asbeck BS, Van Oirschot JF, et al. Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state. Eur J Clin Invest. 2001;31: 417-24. https://doi.org/10.1046/j.1365-2362.2001.00832.x
- Haupt E, Ledermann H, Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther. 2005;43:71-7. https://doi.org/10.5414/CPP43071
- Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg. 1992;94:105-11. https://doi.org/10.1016/0303-8467(92)90066-C
- Yukawa M, Naka H, Murata Y, et al. Folic acid-responsive neurological diseases in Japan. J Nutr Sci Vitaminol. 2001; 47:181-7. https://doi.org/10.3177/jnsv.47.181
- Abbas ZG, Swai AB. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr Med J. 1997;74:803-8.
- Love A, Cotter MA, Cameron NE. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats. Eur J Clin Invest. 1996;26:698-706. https://doi.org/10.1111/j.1365-2362.1996.tb02156.x
- Tandan R, Lewis GA, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy. Effect on sensory function. Diabetes Care. 1992;15:15-8.
-
Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population
${\geq}$ 40 years of age with and without diabete. 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27:1591-7. https://doi.org/10.2337/diacare.27.7.1591 - Clayton PT. B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis. 2006;29:317?26. https://doi.org/10.1007/s10545-005-0243-2
- Major P, Greenberg E, Khan A, Thiele EA. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results. Epilepsy Behav. 2008;13(3):557-9 https://doi.org/10.1016/j.yebeh.2008.07.004
- Ellis JM, Folkers K. Clinical aspects of treatment of carpal tunnel syndrome with B6. Annals of the New York Academy of Science USA. 1990;585 :302-20. https://doi.org/10.1111/j.1749-6632.1990.tb28063.x
- van der Watt JJ, Harrison TB, Benatar M, Heckmann JM. Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV/AIDS era: a systematic review. Int J Tuberc Lung Dis. 2011;15(6):722-8. https://doi.org/10.5588/ijtld.10.0284
- Bender DA. Non-nutritional uses of vitamin B6. Br J Nutr. 1999;81:7-20.